Sarah Jims
Partner
Bio:
Sarah Jims has over a decade of experience in the life sciences industry. In her role, Sarah serves as an experienced consultant to leaders of biotechnology and pharmaceutical organizations in commercial assessment, portfolio strategy, commercialization strategy, and launch readiness. Her expertise spans a variety of therapeutic areas and modalities including cell and gene therapy, rare disease, oncology, and neurology. At Triangle Insights, Sarah leads the Cell and Gene Therapy and New Product Planning and Commercialization centers of excellence.
Prior to Triangle Insights, Sarah earned her PhD in a gene therapy laboratory where she studied gene therapy vector biology, therapeutic optimization, and therapeutic strategies for a variety of disease states.
Degrees: Ph. D. Pharmacology, University of North Carolina Chapel Hill | B.S., Biochemistry and Molecular Biology, University of Richmond